Hubei Guangji Pharmaceutical Co., Ltd. (SHE:000952)
China
· Delayed Price · Currency is CNY 7.27
-0.11 (-1.49%)
Apr 29, 2026, 3:04 PM CST
SHE:000952 Revenue
Hubei Guangji Pharmaceutical had revenue of 163.09M CNY in the quarter ending March 31, 2026, with 9.84% growth. This brings the company's revenue in the last twelve months to 638.58M, up 5.18% year-over-year. In the year 2025, Hubei Guangji Pharmaceutical had annual revenue of 623.97M, down -2.32%.
Revenue (ttm)
638.58M
Revenue Growth
+5.18%
P/S Ratio
4.01
Revenue / Employee
456.78K
Employees
1,398
Market Cap
2.56B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 623.97M | -14.83M | -2.32% |
| Dec 31, 2024 | 638.80M | -99.02M | -13.42% |
| Dec 31, 2023 | 737.82M | -59.82M | -7.50% |
| Jan 1, 2023 | 797.64M | 12.07M | 1.54% |
| Jan 1, 2022 | 785.57M | 97.40M | 14.15% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd | 211.75M |
| Zhejiang Zhenyuan Share | 2.67B |
| Shanghai Shenqi Pharmaceutical Investment Management | 1.88B |
| Guangdong Jiaying Pharmaceutical | 410.00M |
| Zhejiang Haisen Pharmaceutical | 532.26M |
| Shandong Keyuan Pharmaceutical | 448.33M |
| Hangzhou Minsheng Healthcare | 827.65M |
| Zhejiang Int'l Group | 33.68B |